Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- SONAR Committees and Investigators
- Division of Nephrology
- Graduate Institute of Clinical Medicine
- The Ph.D. Program for Translational Medicine
- Graduate Institute of Biomedical Materials and Tissue Engineering
- Master Program in Clinical Genomics and Proteomics
- Taipei Medical University Shuang Ho Hospital
- TMU Research Center of Urology and Kidney
- TMU Research Center of Artificial Intelligence in Medicine and Health
- TMU Research Center of Cell Therapy and Regeneration Medicine
- Interdisciplinary Undergraduate Program in Intelligent Healthcare
Research output: Contribution to journal › Article › peer-review
591
Link opens in a new tab
Citations
(Scopus)